SBI Securities’s InspireMD NSPR Stock Holding History

SBI Securities’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-230	Closed	-$554	–	4162
2025 Q3	$554	Hold	230	–	–	﹤0.01%	2929
2025 Q2	$522	Buy	+230	New	+$573	﹤0.01%	2945

Other funds holding NSPR

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

SBI Securities's NSPR Position: Q4 2025 in Review

SBI Securities sold out of InspireMD (NSPR) in Q4 2025, closing a stake of 230 shares — an estimated $554 sold.

SBI Securities first reported a position in NSPR in Q2 2025 and held it in 2 quarters. The position peaked at $554 in Q3 2025. 45 funds tracked by Wall St. Rank hold NSPR as of Q4 2025.

SBI Securities reported no remaining InspireMD position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 230 InspireMD shares in Q4 2025, an estimated $554.
SBI Securities first reported a position in InspireMD in Q2 2025 and held it in 2 quarters.
SBI Securities's InspireMD position peaked at $554 in Q3 2025.
45 funds tracked by Wall St. Rank held InspireMD as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.